Online citations, reference lists, and bibliographies.
← Back to Search

PEGylated Nanostructured Lipid Carriers (PEG–NLC) As A Novel Drug Delivery System For Biochanin A

L. Wang, Q. Luo, Tongyuan Lin, Rui Li, Tingting Zhu, K. Zhou, Zhaojie Ji, J. Song, Buyun Jia, C. Zhang, Weidong Chen, G. Zhu
Published 2015 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract With the aim to develop a lipid nanoparticle for biochanin A (BCA) by emulsion-evaporation and low temperature-solidification technique. The results revealed that BCA–PEG–NLC not only have small mean particle (148.5 ± 2.88 nm) with narrow polydispersity index (PI) (0.153 ± 0.01), encapsulation capacity (99.62 ± 0.06%), payload (9.06 ± 0.01%), zeta potential (−19.83 ± 1.19 mV), but also slower release rate compared with BCA suspension over 48 h by the dialysis method (n=3). The crystallinity of lipid matrix within BCA–PEG–NLC was evaluated by differential scanning calorimetry (DSC) which verified the BCA successfully into the nanoparticles. Particularly, in pharmacokinetic, the BCA–PEG–NLC of Cmax values and AUC (area under curve) was higher than BCA suspension (approximately 15.8 and 2.9 times, respectively), meanwhile, the mean residence time (MRT) was significantly longer. Furthermore, in vitro cytotoxicity BCA–PEG–NLC showed higher cytotoxicity against MCF-7 cell line compared with BCA suspension. This study suggested that PEG–NLC is a novel anti-cancer nanoparticle, which could provide attractive treatment for a wide variety of tumors and improved the oral bioavailability of poorly water-soluble drug.
This paper references
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1016/j.ijbiomac.2012.01.024
In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
Lejiao Jia (2012)
10.1208/s12249-010-9410-3
Preparation and Enhanced Oral Bioavailability of Cryptotanshinone-Loaded Solid Lipid Nanoparticles
L. Hu (2010)
10.2217/nnm.11.19
Nanoparticle PEGylation for imaging and therapy.
J. Jokerst (2011)
10.1016/S0927-7765(02)00042-5
Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres
K. Makino (2003)
10.1208/s12249-010-9563-0
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
S. Das (2010)
Effect of poly(ethylene glycol) stearate on the phase behavior of monocaprate/Tween80/water system and characterization of poly(ethylene glycol) stearatemodified solid lipid nanoparticles
XW Li (2008)
10.1210/ME.2007-0109
Integration of steroid and growth factor pathways in breast cancer: focus on signal transducers and activators of transcription and their potential role in resistance.
C. Silva (2007)
In vivo studies on the oridoninloaded nanostructured lipid carriers
D Zheng (2012)
10.3109/10717544.2012.704096
In vivo studies on the oridonin-loaded nanostructured lipid carriers
Dandan Zheng (2012)
10.1016/j.ijpharm.2010.05.005
Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
Chun-Yang Zhuang (2010)
10.1016/j.ejphar.2011.11.051
Antihyperglycemic effect of biochanin A, a soy isoflavone, on streptozotocin-diabetic rats.
R. Harini (2012)
10.1007/s11060-006-9126-0
Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) Cells by isoflavones
Shilpa Puli (2006)
10.1016/j.ijpharm.2008.03.030
Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro.
F. Wan (2008)
Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers.
T. Lindmark (1995)
10.1016/J.COLSURFA.2007.08.005
Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers
F. Han (2008)
10.1016/J.COLSURFA.2009.11.006
Optimization of nanostructured lipid carriers for lutein delivery
C. Liu (2010)
10.22377/AJP.V6I4.46
Preparation and characterization of Biochanin A loaded solid lipid nanoparticles
Chunlei Tao (2012)
10.1016/j.jconrel.2009.04.021
Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery.
Jie Shen (2009)
10.1002/JPS.2600711013
Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products.
Y. Tanigawara (1982)
10.1016/j.ejps.2011.04.005
Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.
Tiecheng Zhang (2011)
10.1016/S0378-5173(02)00035-2
Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)--effect of surfactants, storage time and crystallinity.
C. Olbrich (2002)
10.1016/0378-5173(95)04286-5
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
H. Bunjes (1996)
10.1016/j.steroids.2012.03.008
Estrogen receptor-beta and breast cancer: Translating biology into clinical practice
Yuet-Kin Leung (2012)
10.1248/CPB.56.1645
Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
X. Zhang (2008)
A new polymerylipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells
HL Wong (2015)
10.1002/elps.200900336
Capillary electrophoresis of bone marrow stromal cells with uptake of heparin‐functionalized poly(lactide‐co‐glycolide) nanoparticles during differentiation towards neurons
Yung-Chih Kuo (2010)
10.1124/JPET.104.068403
Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates
Xiaobin Jia (2004)
10.1016/j.biomaterials.2011.05.024
Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles.
Adam J. Cole (2011)
10.1016/J.IJPHARM.2007.07.003
Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles.
Jian You (2007)
10.1111/J.1365-2885.1989.TB00654.X
Sustained-release theophylline pharmacokinetics in the cat.
J. Dye (1989)
10.1016/j.ijpharm.2011.04.008
PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
Yuta Yoshizawa (2011)
Preparation and char acterization of Biochanin A loaded solid lipid nanoparticles
C Tao (2012)
10.1016/j.ijpharm.2011.05.044
Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake.
R. Tiwari (2011)
10.1016/j.ijpharm.2011.12.009
Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
Ming-Jun Tsai (2012)
10.1016/j.colsurfb.2012.08.058
Solid lipid nanoparticles as delivery systems for Gambogenic acid.
X. Huang (2013)
10.1007/s11095-006-0282-x
A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells
H. L. Wong (2006)
10.4103/0250-474X.57282
Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System
S. Mukherjee (2009)
10.1002/anie.200902672
Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives.
Katrin Knop (2010)
10.1016/j.ejphar.2010.11.026
Biochanin-A, an isoflavon, showed anti-proliferative and anti-inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking NFκB nuclear translocation.
Labanyamoy Kole (2011)
10.1039/B207838B
Thioalkylated tetraethylene glycol: a new ligand for water soluble monolayer protected gold clusters.
A. G. Kanaras (2002)
10.1615/CRITREVTHERDRUGCARRIERSYST.V20.I5.20
Polymeric micelles for delivery of poorly water-soluble compounds.
G. Kwon (2003)
10.1016/j.biomaterials.2010.11.040
Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.
Adam J. Cole (2011)
10.1615/CRITREVTHERDRUGCARRIERSYST.V27.I5.10
Cancer chemotherapy with lipid-based nanocarriers.
D. Liu (2010)
10.1007/s11095-008-9583-6
Biochanin A Inhibits Breast Cancer Tumor Growth in A Murine Xenograft Model
Young Jin Moon (2008)
10.1016/j.colsurfb.2011.02.038
Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
D. Liu (2011)
10.1079/BJN2000290
Growth inhibition of human endothelial cells by the phyto-oestrogen biochanin A, a metabolite of genistein.
C. Ying (2001)
10.1016/J.COLSURFA.2007.11.011
Effect of poly(ethylene glycol) stearate on the phase behavior of monocaprate/Tween80/water system and characterization of poly(ethylene glycol) stearate-modified solid lipid nanoparticles
Xinwei Li (2008)



This paper is referenced by
10.1016/j.ejps.2017.10.002
Surface‐modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis
F. Kenechukwu (2018)
10.1080/00498254.2016.1229084
Long circulation nanostructured lipid carriers for gambogenic acid: formulation design, characterization, and pharmacokinetic
Tongyuan Lin (2017)
10.1016/j.chroma.2018.10.038
A rapid and efficient technique for liposomal and nonliposomal drug pharmacokinetics studies using magnetic nanoprobes and its application to leakage kinetics of liposomes.
Yunna Chen (2018)
10.3390/pharmaceutics10030074
Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs
X. Zhang (2018)
10.1002/ptr.6115
Phytoestrogens: The current state of research emphasizing breast pathophysiology
H. Anandhi Senthilkumar (2018)
10.1080/03639045.2016.1226337
Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy
Zhihe Lu (2017)
10.1155/2018/3714329
Novel Intravaginal Drug Delivery System Based on Molecularly PEGylated Lipid Matrices for Improved Antifungal Activity of Miconazole Nitrate
F. Kenechukwu (2018)
10.1016/J.CEJ.2019.02.168
Core-shell materials, lipid particles and nanoemulsions, for delivery of active anti-oxidants in cosmetics applications: challenges and development strategies
V. V. Tran (2019)
10.1016/J.JDDST.2019.03.037
In vitro and in vivo evaluation of biotin-mediated PEGylated nanostructured lipid as carrier of disulfiram coupled with copper ion
X. Liu (2019)
10.1016/J.JDDST.2019.02.017
Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier
Vedanti R. Salvi (2019)
10.1016/j.ejpb.2016.08.001
Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation.
S. Doktorovová (2016)
10.1155/2017/1231464
Advances in Hybrid Polymer-Based Materials for Sustained Drug Release
Lígia N M Ribeiro (2017)
10.1080/08982104.2016.1224899
Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy
T. Fu (2017)
10.1016/j.etap.2015.04.020
Therapeutic efficacy of biochanin A against arsenic-induced renal and cardiac damage in rats.
Abdulkadhar Mohamed Jalaludeen (2015)
10.3390/pharmaceutics10040199
Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution
C. Kim (2018)
10.1111/jphp.13003
Preparation, characterization and antimicrobial activity of inclusion complex of biochanin A with (2‐hydroxypropyl)‐β‐cyclodextrin
Ivana Nikolić (2018)
10.2147/IJN.S125041
Enhancing the oral bioavailability of biochanin A by encapsulation in mixed micelles containing Pluronic F127 and Plasdone S630
X. Wu (2017)
10.1016/j.ijpharm.2015.07.036
A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake.
Q. Luo (2015)
10.1016/j.jddst.2020.102269
Multifaceted implementation of nanotechnology in ameliorating therapeutic efficacy of Soy phytoestrogens: Comprehensive review on the state of art
Abdelrahaman Mm. Othman (2021)
10.1080/03639045.2017.1328429
In vitro and in vivo evaluation of folate-mediated PEGylated nanostructured lipid carriers for the efficient delivery of furanodiene
Jianmei Zhang (2017)
10.1016/J.TIFS.2016.06.003
Nanocarriers based delivery of nutraceuticals for cancer prevention and treatment: A review of recent research developments
D. Arora (2016)
10.1007/978-3-030-06115-9_14
Successful Delivery of Zidovudine-Loaded Docosanol Nanostructured Lipid Carriers (Docosanol NLCs) into Rat Brain
Tapash Chakraborty (2019)
10.1080/03639045.2016.1190743
Doxorubicin- and cisplatin-loaded nanostructured lipid carriers for breast cancer combination chemotherapy
H. Di (2016)
10.1016/j.jconrel.2019.01.025
Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers
O. Garbuzenko (2019)
10.1016/B978-0-323-46142-9.00030-X
Role of Excipients in formulation development and biocompatibility of lipid nanoparticles (SLNs/NLCs)
S. Doktorovová (2017)
10.7939/R3GF0NB4Z
Buparvaquone nanostructured lipid carrier development: physicochemical and in vitro leishmanicidal performances
L. M. Monteiro (2017)
10.1016/J.TIFS.2018.07.001
Biochanin A: A phytoestrogen with therapeutic potential
S. Raheja (2018)
10.1049/IET-NBT.2019.0276
Development of tamoxifen-loaded surface-modified nanostructured lipid carrier using experimental design: in vitro and ex vivo characterisation.
G. Poovi (2020)
10.4155/fsoa-2016-0030
Nanostructured lipid carriers: versatile oral delivery vehicle
Neelam Poonia (2016)
10.7282/T3DF6T83
Nanotechnology approach for treatment of cystic fibrosis
N. Kbah (2016)
10.3389/fphar.2019.00793
Perspectives Regarding the Role of Biochanin A in Humans
Chen Yu (2019)
10.2147/IJN.S213229
Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review
Omar Abdifetah (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar